JENNA BROWN: Open Payments
NPI 1275248809 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,900 in 156 payments from 17 companies in 2025. Trend: 2023 $321 · 2024 $1,768 · 2025 $2,900
Food & beverage: $2,550Education: $350
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 22 | $459 |
| ABBVIE INC. | 29 | $454 |
| Incyte Corporation | 19 | $346 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $259 |
| Regeneron Healthcare Solutions, Inc. | 11 | $245 |
| Janssen Biotech, Inc. | 15 | $220 |
| GENZYME CORPORATION | 12 | $214 |
| UCB, Inc. | 9 | $209 |
| E.R. Squibb & Sons, L.L.C. | 15 | $164 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
Products named: DUPIXENT, OPZELURA, VTAMA, RINVOQ, TREMFYA, SKYRIZI, Bimzelx, Sotyktu.
Industry payments across OH — which companies pay providers there.
